Abrdn PLC Pro Qr Therapeutics N.V. Call Options Transaction History
Abrdn PLC
- $50.5 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRQR
# of Institutions
74Shares Held
46.3MCall Options Held
47.5KPut Options Held
6.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.6 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.38 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.52 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$4.75 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.45 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $120M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...